Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLD regimens in COPD patients with different airway microbial types
ChiCTR-OPC-17012653Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Nov 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of gold in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Lung function. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
gold
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-OPC-17012653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17012653.